Brodalumab for Moderate-to-Severe Psoriasis: A Comprehensive Review of Efficacy, Safety, and Clinical Positioning

Babaei N, Gill M, Cervantes M, Kim D, Yang S, Wu JJ

Biologics: Targets and Therapy 2025, 19:415-422

Published Date: 15 July 2025